Geist William — SEC insider filings
SEC reporting owner CIK 1832210. 18 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2020-11-18 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIO-TECHNE Corp (TECH) | PRESIDENT, PROTEIN SCIENCES | 16 | — | — | 50 |
| Quanterix Corp (QTRX) | Chief Operating Officer | 2 | — | — | 3 |
Insider filings — Geist William
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4/A | BIO-TECHNE Corp (TECH) | Option exercise (M): 6,547 @ $0 · Tax withholding (F): 2,019 @ $72.40 · Disposition to issuer (D): 22,545 (derivative) @ $0 · Disposition to issuer (D): 698 (derivative) @ $0 · Option exercise (M): 8,376 (derivative) @ $0 · Option exercise (M): 2,623 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-19 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 14,762 (derivative) @ $0 · Grant/award (A): 23,985 (derivative) @ $0 | EDGAR |
| 2026-08-18 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 6,416 @ $0 · Tax withholding (F): 1,976 @ $72.40 · Option exercise (M): 567 (derivative) @ $0 · Disposition to issuer (D): 8,507 (derivative) @ $0 · Disposition to issuer (D): 22,898 (derivative) @ $0 · Option exercise (M): 2,623 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-05 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 9,911 @ $0 · Tax withholding (F): 4,520 @ $62.57 · Option exercise (M): 9,911 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 2,623 @ $0 · Tax withholding (F): 803 @ $53.60 · Option exercise (M): 2,623 (derivative) @ $0 · Grant/award (A): 19,355 (derivative) @ $0 · Grant/award (A): 9,678 (derivative) @ $0 · Grant/award (A): 24,758 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 3,320 @ $0 · Tax withholding (F): 1,109 @ $73.55 · Option exercise (M): 3,320 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 9,912 @ $0 · Tax withholding (F): 3,270 @ $75.31 · Option exercise (M): 9,912 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 15,738 (derivative) @ $0 · Grant/award (A): 7,869 (derivative) @ $0 · Grant/award (A): 21,204 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | BIO-TECHNE Corp (TECH) | Tax withholding (F): 1,111 @ $68.54 | EDGAR |
| 2023-12-14 | 4/A | BIO-TECHNE Corp (TECH) | Grant/award (A): 9,074 (derivative) @ $0 · Grant/award (A): 24,424 (derivative) @ $0 | EDGAR |
| 2023-11-09 | 4/A | BIO-TECHNE Corp (TECH) | Grant/award (A): 19,823 (derivative) @ $0 | EDGAR |
| 2023-11-03 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 19,857 (derivative) @ $0 | EDGAR |
| 2023-08-17 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 8,377 (derivative) @ $0 · Grant/award (A): 22,544 (derivative) @ $0 · Grant/award (A): 30,059 (derivative) @ $0 | EDGAR |
| 2022-09-29 | 4/A | BIO-TECHNE Corp (TECH) | Grant/award (A): 2,490 (derivative) @ $0 | EDGAR |
| 2022-08-17 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 1,785 (derivative) @ $0 · Grant/award (A): 5,550 (derivative) @ $0 · Grant/award (A): 7,400 (derivative) @ $0 | EDGAR |
| 2022-02-03 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 2,490 @ $0 · Grant/award (A): 840 (derivative) @ $0 · Grant/award (A): 2,984 (derivative) @ $0 · Grant/award (A): 3,978 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 4,906 @ $0 · Grant/award (A): 11,447 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 40,045 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1832210 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs